FDA - Food and Drug Administration
Senate panel questions Trump FDA nominee Heidi Overton on vaccines, abortion pill, agency morale
The agency, responsible for regulating and approving all drugs, treatments, and vaccines, has faced concerns that it has become too political.
Definium's LSD-based drug lowers anxiety in second successful late-stage study
Targeted antibiotic gel helps 80% of pilot patients avoid foot amputation, Jerusalem trial finds
Revolution Medicines gets FDA approval for targeted pancreatic cancer drug
Eating fish while pregnant: Beneficial or detrimental? - study
Study authors concluded that "government recommendations should be reviewed to emphasize the beneficial value of fish consumption during pregnancy."
Pfizer, Moderna's COVID-19 Omicron vaccine boosters approved by US FDA
Pfizer said it has some doses ready to ship immediately and can deliver up to 15 million doses by September 9.
Biden administration to allow new injection method for monkeypox vaccine
The United States declared monkeypox a public health emergency last week, in an effort to bolster the US response to contain the outbreak.
Have breast implants? Israeli study warns they cause autoimmune, mental problems
Lack of FDA supervision, data on side effects hidden by companies resulted in severe autoimmune and mental complications * Permission in 1960s to allow the technology was a “historical medical error”
Israeli company SoniVie receives FDA approval for innovative hypertension treatment
SoniVie’s treatment is called TIVUS – an innovative Ultrasound system that treats Hypertension patients with Renal Artery Denervation.
US, Canada investigate Hepatitis A outbreak linked to strawberries
"Consumption of imported fresh organic strawberries is the likely source of the outbreak," American and Canadian health agencies said.
US FDA clears Pfizer's COVID booster shot for young children
Children below the age of five are not yet eligible for a COVID-19 vaccine in the United States.
State sues Teva over Copaxone drug royalties
Two doctors sued Teva for failing to acknowledge their contributions and demanded to be compensated with royalties stemming from the new version of copaxone.
BioGenCell raises $16m. for chronic disease treatment
The company’s treatment has already prevented loss of limb in several patients during Phase I trials.
Biogen pulls application for Alzheimer's drug in Europe
The drugmaker said the move follows interactions with the European Medicines Agency that suggested data provided so far would not be enough to support an approval.
